Atlas Trials

LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients

Clinical trial NCT00632489 · COMPLETED

Trial details

NCT number
NCT00632489
Sponsor
SCRI Development Innovations, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2008-05-01
Primary completion
2009-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.